Literature DB >> 11274833

Standardisation of imaging in neuroendocrine tumours: results of a European delphi process.

J Ricke1, K J Klose, M Mignon, K Oberg, B Wiedenmann.   

Abstract

In 1998 and 1999, a delphi consensus procedure was performed to establish guidelines for standardised diagnostic imaging of neuroendocrine tumours. The procedure included four consecutive workshops of a European group of experts in neuroendocrine tumours as well as feedback given by specialists from the departments of radiology, nuclear medicine, surgery and internal medicine of the according home institutions. Diverging approaches among the centres, which became apparent during the discussion, reflect a lack of controlled studies specifically for rare subgroups of neuroendocrine tumours. This paper summarises the standards for diagnostic imaging as developed during the delphi process. In particular, the diagnostic workflows as well as the technical properties of different imaging modalities are described in detail.

Entities:  

Mesh:

Year:  2001        PMID: 11274833     DOI: 10.1016/s0720-048x(00)00187-x

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  17 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Imaging of gastroenteropancreatic neuroendocrine tumors.

Authors:  Eik Hock Tan; Cher Heng Tan
Journal:  World J Clin Oncol       Date:  2011-01-10

3.  Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.

Authors:  Martin Gotthardt; Martin P Béhé; Daniela Beuter; Anke Battmann; Artur Bauhofer; Tino Schurrat; Meike Schipper; Halina Pollum; Wim J G Oyen; Thomas M Behr
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-11       Impact factor: 9.236

Review 4.  The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines.

Authors:  Wouter T Zandee; Wouter W de Herder
Journal:  Neuroendocrinology       Date:  2018-01-10       Impact factor: 4.914

5.  Imaging features of malignant abdominal neuroendocrine tumors with rare presentation.

Authors:  Giuseppe Corrias; Serena Monti; Natally Horvat; Laura Tang; Olca Basturk; Luca Saba; Lorenzo Mannelli
Journal:  Clin Imaging       Date:  2018-02-08       Impact factor: 1.605

Review 6.  Treatment of Zollinger-Ellison syndrome.

Authors:  Paola Tomassetti; Davide Campana; Lydia Piscitelli; Elena Mazzotta; Emilio Brocchi; Raffaele Pezzilli; Roberto Corinaldesi
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

7.  Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?

Authors:  H Amthauer; J Ruf; M Böhmig; E Lopez-Hänninen; T Rohlfing; K-D Wernecke; U Plöckinger; M Gutberlet; A-J Lemke; T Steinmüller; B Wiedenmann; R Felix
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-03       Impact factor: 9.236

8.  Periampullary mass--a rare presentation of poorly differentiated neuroendocrine cancer of duodenum in a young adult: a case report and review of literature.

Authors:  Neha Singh; Hemanta K Nayak; Avishek Bagchi; Premashis Kar
Journal:  BMJ Case Rep       Date:  2012-10-09

9.  Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe 1-Tyr 3-octreotide and chromogranin A assay in patients with neuroendocrine tumours.

Authors:  Margarida Rodrigues; Michael Gabriel; Dirk Heute; Daniel Putzer; Andrea Griesmacher; Irene Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-19       Impact factor: 9.236

10.  Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy.

Authors:  Michael Bellutti; Lucia C Fry; Johannes Schmitt; Marcus Seemann; Silke Klose; Peter Malfertheiner; Klaus Mönkemüller
Journal:  Dig Dis Sci       Date:  2008-09-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.